Modular Medical (MODD) Competitors

$3.36 -0.01 (-0.30%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$3.37 +0.01 (+0.18%)

As of 07:00 AM Eastern

MODD vs. APT, DRIO, SRTS, LUNG, and NSPR

Should you buy Modular Medical stock or one of its competitors? MarketBeat compares Modular Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Modular Medical include Alpha Pro Tech (APT), DarioHealth (DRIO), Sensus Healthcare (SRTS), Pulmonx (LUNG), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.

How does Modular Medical compare to Alpha Pro Tech?

Modular Medical (NASDAQ:MODD) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, Alpha Pro Tech had 5 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Alpha Pro Tech and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.87 beat Alpha Pro Tech's score of -0.39 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Very Positive
Alpha Pro Tech	Neutral

Modular Medical has a beta of 0.24, meaning that its stock price is 76% less volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

Alpha Pro Tech has a net margin of 6.99% compared to Modular Medical's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
Alpha Pro Tech	6.99%	6.70%	5.76%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Alpha Pro Tech has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
Alpha Pro Tech	$59.91M	1.06	$4.19M	$0.35	17.71

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Alpha Pro Tech beats Modular Medical on 10 of the 13 factors compared between the two stocks.

How does Modular Medical compare to DarioHealth?

Modular Medical (NASDAQ:MODD) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Modular Medical has a net margin of 0.00% compared to DarioHealth's net margin of -192.23%. DarioHealth's return on equity of -60.52% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
DarioHealth	-192.23%	-60.52%	-37.08%

Modular Medical has higher earnings, but lower revenue than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
DarioHealth	$22.36M	2.73	-$41.71M	-$8.88	N/A

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by insiders. Comparatively, 3.5% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Modular Medical has a beta of 0.24, meaning that its share price is 76% less volatile than the broader market. Comparatively, DarioHealth has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

DarioHealth has a consensus price target of $10.50, indicating a potential upside of 25.75%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts plainly believe DarioHealth is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, DarioHealth had 7 more articles in the media than Modular Medical. MarketBeat recorded 7 mentions for DarioHealth and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.87 beat DarioHealth's score of 0.81 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Very Positive
DarioHealth	Positive

Summary

DarioHealth beats Modular Medical on 10 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Sensus Healthcare?

Modular Medical (NASDAQ:MODD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Modular Medical has a beta of 0.24, meaning that its share price is 76% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Sensus Healthcare has higher revenue and earnings than Modular Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
Sensus Healthcare	$27.48M	2.08	-$7.72M	-$0.47	N/A

In the previous week, Sensus Healthcare had 2 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Sensus Healthcare and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.87 beat Sensus Healthcare's score of 1.43 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Very Positive
Sensus Healthcare	Positive

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to Sensus Healthcare's net margin of -34.50%. Sensus Healthcare's return on equity of -15.79% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
Sensus Healthcare	-34.50%	-15.79%	-14.02%

Sensus Healthcare has a consensus target price of $6.88, indicating a potential upside of 98.13%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Sensus Healthcare beats Modular Medical on 11 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Pulmonx?

Modular Medical (NASDAQ:MODD) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Modular Medical has a net margin of 0.00% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
Pulmonx	-60.09%	-92.94%	-39.80%

Modular Medical has a beta of 0.24, indicating that its stock price is 76% less volatile than the broader market. Comparatively, Pulmonx has a beta of 0.18, indicating that its stock price is 82% less volatile than the broader market.

In the previous week, Modular Medical's average media sentiment score of 1.87 equaled Pulmonx'saverage media sentiment score.

Company	Overall Sentiment
Modular Medical	Very Positive
Pulmonx	Very Positive

Modular Medical has higher earnings, but lower revenue than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
Pulmonx	$90.50M	0.61	-$54M	-$1.30	N/A

Pulmonx has a consensus price target of $5.38, indicating a potential upside of 310.58%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts clearly believe Pulmonx is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pulmonx	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 7.1% of Modular Medical shares are held by insiders. Comparatively, 6.8% of Pulmonx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Pulmonx beats Modular Medical on 8 of the 13 factors compared between the two stocks.

How does Modular Medical compare to InspireMD?

Modular Medical (NASDAQ:MODD) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Modular Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
InspireMD	-413.96%	-69.42%	-57.68%

Modular Medical has a beta of 0.24, suggesting that its stock price is 76% less volatile than the broader market. Comparatively, InspireMD has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 34.1% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Modular Medical has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
InspireMD	$10.85M	4.53	-$19.92M	-$0.73	N/A

In the previous week, InspireMD had 8 more articles in the media than Modular Medical. MarketBeat recorded 8 mentions for InspireMD and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.87 beat InspireMD's score of 0.78 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Very Positive
InspireMD	Positive

InspireMD has a consensus target price of $4.50, suggesting a potential upside of 328.57%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

InspireMD beats Modular Medical on 11 of the 15 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MODD vs. The Competition

Export

Metric	Modular Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$15.71M	$8.09B	$6.25B	$12.29B
Dividend Yield	N/A	2.53%	2.80%	5.32%
P/E Ratio	-0.23	16.00	20.64	25.23
Price / Sales	N/A	6.07	554.85	79.36
Price / Cash	N/A	16.74	27.48	37.30
Price / Book	0.27	3.58	9.66	6.63
Net Income	-$18.82M	$224.05M	$3.56B	$335.59M
7 Day Performance	-6.41%	-2.35%	-1.65%	-1.20%
1 Month Performance	-42.66%	-3.00%	-2.60%	-1.16%
1 Year Performance	-88.57%	0.66%	30.07%	28.10%

Modular Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MODD Modular Medical	1.1927 of 5 stars	$3.36 -0.3%	N/A	-88.5%	$15.71M	N/A	N/A	20	Positive News Gap Down
APT Alpha Pro Tech	N/A	$6.11 -3.9%	N/A	+39.0%	$62.38M	$59.91M	16.50	120	News Coverage
DRIO DarioHealth	2.9281 of 5 stars	$8.26 -4.9%	$35.00 +324.0%	-36.7%	$60.26M	$22.36M	N/A	200	Gap Up
SRTS Sensus Healthcare	3.8672 of 5 stars	$3.47 +3.0%	$6.88 +98.1%	-22.2%	$57.12M	$27.48M	N/A	40
LUNG Pulmonx	2.6439 of 5 stars	$1.32 +1.9%	$5.38 +309.0%	-61.8%	$55.55M	$90.50M	N/A	250	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MODD) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Modular Medical (MODD) Competitors

MODD vs. APT, DRIO, SRTS, LUNG, and NSPR

How does Modular Medical compare to Alpha Pro Tech?

Summary

How does Modular Medical compare to DarioHealth?

Summary

How does Modular Medical compare to Sensus Healthcare?

Summary

How does Modular Medical compare to Pulmonx?

Summary

How does Modular Medical compare to InspireMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Modular Medical (MODD) Competitors

MODD vs. APT, DRIO, SRTS, LUNG, and NSPR

How does Modular Medical compare to Alpha Pro Tech?

Does the media prefer MODD or APT?

Which has more volatility and risk, MODD or APT?

Is MODD or APT more profitable?

Do analysts prefer MODD or APT?

Which has better valuation & earnings, MODD or APT?

Do insiders and institutionals have more ownership in MODD or APT?

Summary

How does Modular Medical compare to DarioHealth?

Is MODD or DRIO more profitable?

Which has higher earnings and valuation, MODD or DRIO?

Do insiders & institutionals have more ownership in MODD or DRIO?

Which has more risk & volatility, MODD or DRIO?

Do analysts rate MODD or DRIO?

Does the media prefer MODD or DRIO?

Summary

How does Modular Medical compare to Sensus Healthcare?

Which has more risk and volatility, MODD or SRTS?

Which has preferable earnings & valuation, MODD or SRTS?

Does the media prefer MODD or SRTS?

Do institutionals and insiders have more ownership in MODD or SRTS?

Is MODD or SRTS more profitable?

Do analysts rate MODD or SRTS?

Summary

How does Modular Medical compare to Pulmonx?

Is MODD or LUNG more profitable?

Which has more volatility & risk, MODD or LUNG?

Does the media prefer MODD or LUNG?

Which has stronger earnings and valuation, MODD or LUNG?

Do analysts recommend MODD or LUNG?

Do institutionals & insiders believe in MODD or LUNG?

Summary

How does Modular Medical compare to InspireMD?

Is MODD or NSPR more profitable?

Which has more volatility & risk, MODD or NSPR?

Do institutionals & insiders hold more shares of MODD or NSPR?

Which has preferable valuation and earnings, MODD or NSPR?

Does the media favor MODD or NSPR?

Do analysts prefer MODD or NSPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools